Back

The long-term clinical course of moderate tricuspid regurgitation

29 August 2022 (12:15 - 12:55)
Organised by:
Congress Presentation Part of: Epidemiology, prognosis, course, and outcome of valvular heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Davide Margonato

San Raffaele Hospital, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Tricuspid regurgitation: frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP valvular heart disease II survey
Doctor J. Dreyfus (Saint-Denis, FR)
Abstract Slides
Presentation thumbnail
Outcomes benefit in asymptomatic patients with moderate aortic valve stenosis followed up in heart valve clinics
Doctor P. Paolisso (Rome, IT)
Abstract Slides
Presentation thumbnail
Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis
Associate Professor A. Coisne (Lille, FR)
Abstract Slides
Presentation thumbnail
Heritability and environmental influences on the onset of aortic valve sclerosis: a twin population study
Doctor P. Poggio (Milan, IT)
Abstract Slides
Presentation thumbnail
Modeling aortic stenosis progression: impact on follow-up, treatment and survival
Doctor R. Teixeira (Vila Nova de Gaia, PT)
Abstract Slides

Access the full session

Session thumbnail
Epidemiology, prognosis, course, and outcome of valvular heart disease

The Event

Event poster

ESC Congress 2022

29 August 2022 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular function and systolic pressure effect on survival of patients with tricuspid regurgitation
28 August 2020
thumbnail
Congress Session
Management of moderate valvular heart disease
31 August 2025
thumbnail
Congress Presentation
Long-term follow-up of patients undergoing emergency transcatheter mitral valve repair.
21 March 2026
thumbnail
Congress Presentation
Tricuspid regurgitation: a narrative review focused on the missing points in the management of the less noble valve disease, directed to clinical practice
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources